Speaker Profile
M.D.,Ph.D., Division Chief of Radiation and Cancer Biology, Stanford
Biography
Maximilian Diehn received his Bachelors Degree in Biochemical Sciences from Harvard College and his M.D.Ph.D. in Biophysics from Stanford University. He is a board certified Radiation Oncologist and specializes in the treatment of lung cancers. Dr. Diehns current research program spans laboratory, translational, and clinical studies. His areas of interest include cancer genomics, stem cell biology, and lung cancer biology. His work has been recognized with a variety of awards, including the V Foundation Scholar Award, the Sidney Kimmel Scholar Award, the Doris Duke Clinical Scientist Development Award, and the NIH Directors New Innovator Award. His group has developed an ultra sensitive and specific method for detection of circulating tumor DNA called CAPP-Seq. Current work is focused on applying CAPP-Seq to a range of clinical contexts, with an emphasis on tumor heterogeneity and minimal residual disease.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Adrian Lee, University of Pittsburgh
PMWC Award Ceremony Honorees
• Dennis J. Slamon, UCLA
Neoadjuvant to Adjuvant MRD: How Early Is Early Enough?
• Chair: Angela DeMichele, UPenn
• Halla Nimeiri, Tempus
• Aparna Parikh, Harvard
• Minetta Liu, Natera
Serial ctDNA-Guided Therapy Switching (SERENA-6 & Beyond)
• Chair: Pedram Razavi, MSK
Multi-Omics Monitoring Beyond Variants: Methylation, Fragmentomics, EV/ctRNA
• David T. Miyamoto, Massachusetts General Hospital
• Maximilian Diehn, Stanford
From Validation to Payment: Coverage Pathways That Work
• Mark Stewart, Friends of Cancer Research
From Validation to Payment: Coverage Pathways That Work
• Mark Stewart, Friends of Cancer Research
• Hilary Gee Goeckner, American Cancer Society (ACS)
• Sally Werner, Cancer Support Community
• Gabriel A. Bien-Willner, Palmetto GBA
